ACTH-secreting medullary thyroid cancer: a case series.

about

ACTH-secreting medullary thyroid cancer: a case series.

Item

http://www.wikidata.org/entity/Q42014281

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

ACTH-secreting medullary thyroid cancer: a case series.

@en

ACTH-secreting medullary thyroid cancer: a case series.

@nl

type

Item

label

ACTH-secreting medullary thyroid cancer: a case series.

@en

ACTH-secreting medullary thyroid cancer: a case series.

@nl

prefLabel

ACTH-secreting medullary thyroid cancer: a case series.

@en

ACTH-secreting medullary thyroid cancer: a case series.

@nl

P1476

ACTH-secreting medullary thyroid cancer: a case series.

@en

P2093

Ayanthi A Wijewardene

http://www.w3.org/2001/XMLSchema#string

Bruce G Robinson

http://www.w3.org/2001/XMLSchema#string

Diana L Learoyd

http://www.w3.org/2001/XMLSchema#string

Sarah J Glastras

http://www.w3.org/2001/XMLSchema#string

Venessa H M Tsang

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: a systematic review and meta-analysis

Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient.

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

6: Thyroid nodules and thyroid cancer.

Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature.

Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature.

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.

Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma.

P31

scholarly article

P356

10.1530/EDM-16-0110

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28567290

http://www.w3.org/2001/XMLSchema#string

P932

5445425

http://www.w3.org/2001/XMLSchema#string